Synthesis of new N,N'-bis(5-arylidene-4-oxo- 4,5-dihydrothiazolin-2-yl)piperazine derivatives under microwave irradiation and preliminary biological evaluation

14Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

New N,N'-bis(5-arylidene-4-oxo-4,5-dihydrothiazoline-2-yl)diamine derivatives 5 were prepared in two steps from rhodanine and piperazine, or 1,4-bis(3-amino-propyl)piperazine, under microwave reaction conditions with retention of configuration. Some of these compounds were tested for in vitro antiproliferative activities and for their kinase inhibitory potencies towards six kinases (CDK5/p25, GSK3α/β, DYRK1A, DYRK2, CLK1, and CLK2). The compound 5d showed nanomolar activity towards DYRK1A kinase (IC50 = 0.041 μM). © Coulibaly et al.

Cite

CITATION STYLE

APA

Coulibaly, W. K., Paquin, L., Bénié, A., Bekro, Y. A., Durieux, E., Meijer, L., … Bazureau, J. P. (2012). Synthesis of new N,N’-bis(5-arylidene-4-oxo- 4,5-dihydrothiazolin-2-yl)piperazine derivatives under microwave irradiation and preliminary biological evaluation. Scientia Pharmaceutica, 80(4), 825–836. https://doi.org/10.3797/scipharm.1206-04

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free